Billion-Dollar Risperdal Settlement Delayed Over Breast Growth Warnings

May 24, 2014
by Adler Markoff & Associates

Request A Free Consultation

(405) 607-8757

    Billion-Dollar Risperdal Settlement Delayed Over Breast Growth Warnings

    A $2.2 billion Risperdal settlement between the federal government and pharmaceutical giant Johnson & Johnson may be delayed by Department of Justice (DOJ) demands that the drug firm acknowledge the risk of Risperdal breast growth side effects. The significant settlement was decided upon following a federal probe into the illegal marketing of J&J’s Risperdal antipsychotic drug, which has been tied to abnormal breast growth in young men who took the medication as boys. If you took the antipsychotic drug Risperdal, and you have since experienced abnormal breast growth side effects, contact our reputable attorneys at AMA Law for legal help. You may be entitled to financial compensation for your injuries and medical bills, which our attorneys can help you pursue.


    As part of the pending Risperdal settlement, the federal government wants Johnson & Johnson to admit that the drug company downplayed the risk of breast growth side effects associated with the antipsychotic drug when it sought approval to market Risperdal to young children. This acknowledgment on J&J’s part could expose the drug firm to a number of lawsuits filed on behalf of former users of the atypical antipsychotic who experienced abnormal breast growth after taking the medication. Johnson & Johnson already faces dozens of Risperdal complaints brought on behalf of teen boys who suffered breast growth side effects after using the antipsychotic drug as children.


    According to allegations raised in pending Risperdal lawsuits, Johnson & Johnson is accused of failing to adequately research the antipsychotic drug or warn consumers about the risk of boys growing breasts if they take the medication. In September 2012, J&J settled a Risperdal lawsuit filed on behalf of a 21-year-old who claimed that side effects of the antipsychotic medication caused him to experience psychological trauma and resulted in him undergoing surgery to have the breasts removed. Additional Risperdal cases are pending in state courts throughout the United States, and the number of complaints brought is expected to increase as young men with abnormal breast growth discover their problems may be related to Risperdal use.


    Risperdal was initially introduced by Johnson & Johnson as a treatment for patients suffering from schizophrenia, although the drug company has since been accused of illegally marketing the medication for off-label uses. If you have suffered complications like abnormal breast growth and you believe J&J’s antipsychotic drug Risperdal to be the cause, consult our qualified lawyers at AMA Law today to explore your compensation options. You may have grounds to file a product liability lawsuit against drug maker Johnson & Johnson, in order to seek fair and timely reimbursement for your injuries, medical expenses, pain and suffering, and any other damages possibly related to the medication Risperdal.

    Request a free consultation

    (405) 607-8757